CBRN Oversuits
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global TDS (Transdermal Delivery Systems) Market Research Report 2024
1 TDS (Transdermal Delivery Systems) Market Overview
1.1 Product Overview and Scope of TDS (Transdermal Delivery Systems)
1.2 TDS (Transdermal Delivery Systems) Segment by Type
1.2.1 Global TDS (Transdermal Delivery Systems) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Single-layer Drug-in-Adhesive
1.2.3 Multi-layer Drug-in-Adhesive
1.2.4 Others
1.3 TDS (Transdermal Delivery Systems) Segment by Application
1.3.1 Global TDS (Transdermal Delivery Systems) Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global TDS (Transdermal Delivery Systems) Market Size Estimates and Forecasts
1.4.1 Global TDS (Transdermal Delivery Systems) Revenue 2017-2028
1.4.2 Global TDS (Transdermal Delivery Systems) Sales 2017-2028
1.4.3 TDS (Transdermal Delivery Systems) Market Size by Region: 2017 Versus 2021 Versus 2028
2 TDS (Transdermal Delivery Systems) Market Competition by Manufacturers
2.1 Global TDS (Transdermal Delivery Systems) Sales Market Share by Manufacturers (2017-2022)
2.2 Global TDS (Transdermal Delivery Systems) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global TDS (Transdermal Delivery Systems) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers TDS (Transdermal Delivery Systems) Manufacturing Sites, Area Served, Product Type
2.5 TDS (Transdermal Delivery Systems) Market Competitive Situation and Trends
2.5.1 TDS (Transdermal Delivery Systems) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest TDS (Transdermal Delivery Systems) Players Market Share by Revenue
2.5.3 Global TDS (Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 TDS (Transdermal Delivery Systems) Retrospective Market Scenario by Region
3.1 Global TDS (Transdermal Delivery Systems) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global TDS (Transdermal Delivery Systems) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America TDS (Transdermal Delivery Systems) Market Facts & Figures by Country
3.3.1 North America TDS (Transdermal Delivery Systems) Sales by Country
3.3.2 North America TDS (Transdermal Delivery Systems) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe TDS (Transdermal Delivery Systems) Market Facts & Figures by Country
3.4.1 Europe TDS (Transdermal Delivery Systems) Sales by Country
3.4.2 Europe TDS (Transdermal Delivery Systems) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific TDS (Transdermal Delivery Systems) Market Facts & Figures by Region
3.5.1 Asia Pacific TDS (Transdermal Delivery Systems) Sales by Region
3.5.2 Asia Pacific TDS (Transdermal Delivery Systems) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America TDS (Transdermal Delivery Systems) Market Facts & Figures by Country
3.6.1 Latin America TDS (Transdermal Delivery Systems) Sales by Country
3.6.2 Latin America TDS (Transdermal Delivery Systems) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa TDS (Transdermal Delivery Systems) Market Facts & Figures by Country
3.7.1 Middle East and Africa TDS (Transdermal Delivery Systems) Sales by Country
3.7.2 Middle East and Africa TDS (Transdermal Delivery Systems) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global TDS (Transdermal Delivery Systems) Historic Market Analysis by Type
4.1 Global TDS (Transdermal Delivery Systems) Sales Market Share by Type (2017-2022)
4.2 Global TDS (Transdermal Delivery Systems) Revenue Market Share by Type (2017-2022)
4.3 Global TDS (Transdermal Delivery Systems) Price by Type (2017-2022)
5 Global TDS (Transdermal Delivery Systems) Historic Market Analysis by Application
5.1 Global TDS (Transdermal Delivery Systems) Sales Market Share by Application (2017-2022)
5.2 Global TDS (Transdermal Delivery Systems) Revenue Market Share by Application (2017-2022)
5.3 Global TDS (Transdermal Delivery Systems) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Adhex Pharma
6.1.1 Adhex Pharma Corporation Information
6.1.2 Adhex Pharma Description and Business Overview
6.1.3 Adhex Pharma TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Adhex Pharma TDS (Transdermal Delivery Systems) Product Portfolio
6.1.5 Adhex Pharma Recent Developments/Updates
6.2 Harro Hofliger
6.2.1 Harro Hofliger Corporation Information
6.2.2 Harro Hofliger Description and Business Overview
6.2.3 Harro Hofliger TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Harro Hofliger TDS (Transdermal Delivery Systems) Product Portfolio
6.2.5 Harro Hofliger Recent Developments/Updates
6.3 Tesa Labtec
6.3.1 Tesa Labtec Corporation Information
6.3.2 Tesa Labtec Description and Business Overview
6.3.3 Tesa Labtec TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Tesa Labtec TDS (Transdermal Delivery Systems) Product Portfolio
6.3.5 Tesa Labtec Recent Developments/Updates
6.4 Toyochem
6.4.1 Toyochem Corporation Information
6.4.2 Toyochem Description and Business Overview
6.4.3 Toyochem TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Toyochem TDS (Transdermal Delivery Systems) Product Portfolio
6.4.5 Toyochem Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Corporation Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Teva Pharmaceutical TDS (Transdermal Delivery Systems) Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Pfizer TDS (Transdermal Delivery Systems) Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 IBSA Group
6.6.1 IBSA Group Corporation Information
6.6.2 IBSA Group Description and Business Overview
6.6.3 IBSA Group TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 IBSA Group TDS (Transdermal Delivery Systems) Product Portfolio
6.7.5 IBSA Group Recent Developments/Updates
6.8 Teikoku Seiyaku
6.8.1 Teikoku Seiyaku Corporation Information
6.8.2 Teikoku Seiyaku Description and Business Overview
6.8.3 Teikoku Seiyaku TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Teikoku Seiyaku TDS (Transdermal Delivery Systems) Product Portfolio
6.8.5 Teikoku Seiyaku Recent Developments/Updates
6.9 Endo International
6.9.1 Endo International Corporation Information
6.9.2 Endo International Description and Business Overview
6.9.3 Endo International TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Endo International TDS (Transdermal Delivery Systems) Product Portfolio
6.9.5 Endo International Recent Developments/Updates
6.10 Hisamitsu
6.10.1 Hisamitsu Corporation Information
6.10.2 Hisamitsu Description and Business Overview
6.10.3 Hisamitsu TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Hisamitsu TDS (Transdermal Delivery Systems) Product Portfolio
6.10.5 Hisamitsu Recent Developments/Updates
6.11 Mylan
6.11.1 Mylan Corporation Information
6.11.2 Mylan TDS (Transdermal Delivery Systems) Description and Business Overview
6.11.3 Mylan TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Mylan TDS (Transdermal Delivery Systems) Product Portfolio
6.11.5 Mylan Recent Developments/Updates
6.12 Sorrento Therapeutics
6.12.1 Sorrento Therapeutics Corporation Information
6.12.2 Sorrento Therapeutics TDS (Transdermal Delivery Systems) Description and Business Overview
6.12.3 Sorrento Therapeutics TDS (Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Sorrento Therapeutics TDS (Transdermal Delivery Systems) Product Portfolio
6.12.5 Sorrento Therapeutics Recent Developments/Updates
7 TDS (Transdermal Delivery Systems) Manufacturing Cost Analysis
7.1 TDS (Transdermal Delivery Systems) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of TDS (Transdermal Delivery Systems)
7.4 TDS (Transdermal Delivery Systems) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 TDS (Transdermal Delivery Systems) Distributors List
8.3 TDS (Transdermal Delivery Systems) Customers
9 TDS (Transdermal Delivery Systems) Market Dynamics
9.1 TDS (Transdermal Delivery Systems) Industry Trends
9.2 TDS (Transdermal Delivery Systems) Market Drivers
9.3 TDS (Transdermal Delivery Systems) Market Challenges
9.4 TDS (Transdermal Delivery Systems) Market Restraints
10 Global Market Forecast
10.1 TDS (Transdermal Delivery Systems) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of TDS (Transdermal Delivery Systems) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of TDS (Transdermal Delivery Systems) by Type (2023-2028)
10.2 TDS (Transdermal Delivery Systems) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of TDS (Transdermal Delivery Systems) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of TDS (Transdermal Delivery Systems) by Application (2023-2028)
10.3 TDS (Transdermal Delivery Systems) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of TDS (Transdermal Delivery Systems) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of TDS (Transdermal Delivery Systems) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global TDS (Transdermal Delivery Systems) Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global TDS (Transdermal Delivery Systems) Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global TDS (Transdermal Delivery Systems) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global TDS (Transdermal Delivery Systems) Market Competitive Situation by Manufacturers in 2021
Table 5. Global TDS (Transdermal Delivery Systems) Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global TDS (Transdermal Delivery Systems) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global TDS (Transdermal Delivery Systems) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global TDS (Transdermal Delivery Systems) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market TDS (Transdermal Delivery Systems) Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers TDS (Transdermal Delivery Systems) Manufacturing Sites and Area Served
Table 11. Manufacturers TDS (Transdermal Delivery Systems) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global TDS (Transdermal Delivery Systems) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TDS (Transdermal Delivery Systems) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global TDS (Transdermal Delivery Systems) Sales by Region (2017-2022) & (K Units)
Table 16. Global TDS (Transdermal Delivery Systems) Sales Market Share by Region (2017-2022)
Table 17. Global TDS (Transdermal Delivery Systems) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global TDS (Transdermal Delivery Systems) Revenue Market Share by Region (2017-2022)
Table 19. North America TDS (Transdermal Delivery Systems) Sales by Country (2017-2022) & (K Units)
Table 20. North America TDS (Transdermal Delivery Systems) Sales Market Share by Country (2017-2022)
Table 21. North America TDS (Transdermal Delivery Systems) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America TDS (Transdermal Delivery Systems) Revenue Market Share by Country (2017-2022)
Table 23. Europe TDS (Transdermal Delivery Systems) Sales by Country (2017-2022) & (K Units)
Table 24. Europe TDS (Transdermal Delivery Systems) Sales Market Share by Country (2017-2022)
Table 25. Europe TDS (Transdermal Delivery Systems) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe TDS (Transdermal Delivery Systems) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific TDS (Transdermal Delivery Systems) Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific TDS (Transdermal Delivery Systems) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific TDS (Transdermal Delivery Systems) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific TDS (Transdermal Delivery Systems) Revenue Market Share by Region (2017-2022)
Table 31. Latin America TDS (Transdermal Delivery Systems) Sales by Country (2017-2022) & (K Units)
Table 32. Latin America TDS (Transdermal Delivery Systems) Sales Market Share by Country (2017-2022)
Table 33. Latin America TDS (Transdermal Delivery Systems) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America TDS (Transdermal Delivery Systems) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa TDS (Transdermal Delivery Systems) Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa TDS (Transdermal Delivery Systems) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa TDS (Transdermal Delivery Systems) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa TDS (Transdermal Delivery Systems) Revenue Market Share by Country (2017-2022)
Table 39. Global TDS (Transdermal Delivery Systems) Sales by Type (2017-2022) & (K Units)
Table 40. Global TDS (Transdermal Delivery Systems) Sales Market Share by Type (2017-2022)
Table 41. Global TDS (Transdermal Delivery Systems) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global TDS (Transdermal Delivery Systems) Revenue Share by Type (2017-2022)
Table 43. Global TDS (Transdermal Delivery Systems) Price by Type (2017-2022) & (USD/Unit)
Table 44. Global TDS (Transdermal Delivery Systems) Sales (K Units) by Application (2017-2022)
Table 45. Global TDS (Transdermal Delivery Systems) Sales Market Share by Application (2017-2022)
Table 46. Global TDS (Transdermal Delivery Systems) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global TDS (Transdermal Delivery Systems) Revenue Share by Application (2017-2022)
Table 48. Global TDS (Transdermal Delivery Systems) Price by Application (2017-2022) & (USD/Unit)
Table 49. Adhex Pharma Corporation Information
Table 50. Adhex Pharma Description and Business Overview
Table 51. Adhex Pharma TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Adhex Pharma TDS (Transdermal Delivery Systems) Product
Table 53. Adhex Pharma Recent Developments/Updates
Table 54. Harro Hofliger Corporation Information
Table 55. Harro Hofliger Description and Business Overview
Table 56. Harro Hofliger TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Harro Hofliger TDS (Transdermal Delivery Systems) Product
Table 58. Harro Hofliger Recent Developments/Updates
Table 59. Tesa Labtec Corporation Information
Table 60. Tesa Labtec Description and Business Overview
Table 61. Tesa Labtec TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Tesa Labtec TDS (Transdermal Delivery Systems) Product
Table 63. Tesa Labtec Recent Developments/Updates
Table 64. Toyochem Corporation Information
Table 65. Toyochem Description and Business Overview
Table 66. Toyochem TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Toyochem TDS (Transdermal Delivery Systems) Product
Table 68. Toyochem Recent Developments/Updates
Table 69. Teva Pharmaceutical Corporation Information
Table 70. Teva Pharmaceutical Description and Business Overview
Table 71. Teva Pharmaceutical TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Teva Pharmaceutical TDS (Transdermal Delivery Systems) Product
Table 73. Teva Pharmaceutical Recent Developments/Updates
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Business Overview
Table 76. Pfizer TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Pfizer TDS (Transdermal Delivery Systems) Product
Table 78. Pfizer Recent Developments/Updates
Table 79. IBSA Group Corporation Information
Table 80. IBSA Group Description and Business Overview
Table 81. IBSA Group TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. IBSA Group TDS (Transdermal Delivery Systems) Product
Table 83. IBSA Group Recent Developments/Updates
Table 84. Teikoku Seiyaku Corporation Information
Table 85. Teikoku Seiyaku Description and Business Overview
Table 86. Teikoku Seiyaku TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Teikoku Seiyaku TDS (Transdermal Delivery Systems) Product
Table 88. Teikoku Seiyaku Recent Developments/Updates
Table 89. Endo International Corporation Information
Table 90. Endo International Description and Business Overview
Table 91. Endo International TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Endo International TDS (Transdermal Delivery Systems) Product
Table 93. Endo International Recent Developments/Updates
Table 94. Hisamitsu Corporation Information
Table 95. Hisamitsu Description and Business Overview
Table 96. Hisamitsu TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Hisamitsu TDS (Transdermal Delivery Systems) Product
Table 98. Hisamitsu Recent Developments/Updates
Table 99. Mylan Corporation Information
Table 100. Mylan Description and Business Overview
Table 101. Mylan TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Mylan TDS (Transdermal Delivery Systems) Product
Table 103. Mylan Recent Developments/Updates
Table 104. Sorrento Therapeutics Corporation Information
Table 105. Sorrento Therapeutics Description and Business Overview
Table 106. Sorrento Therapeutics TDS (Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Sorrento Therapeutics TDS (Transdermal Delivery Systems) Product
Table 108. Sorrento Therapeutics Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. TDS (Transdermal Delivery Systems) Distributors List
Table 112. TDS (Transdermal Delivery Systems) Customers List
Table 113. TDS (Transdermal Delivery Systems) Market Trends
Table 114. TDS (Transdermal Delivery Systems) Market Drivers
Table 115. TDS (Transdermal Delivery Systems) Market Challenges
Table 116. TDS (Transdermal Delivery Systems) Market Restraints
Table 117. Global TDS (Transdermal Delivery Systems) Sales Forecast by Type (2023-2028) & (K Units)
Table 118. Global TDS (Transdermal Delivery Systems) Sales Market Share Forecast by Type (2023-2028)
Table 119. Global TDS (Transdermal Delivery Systems) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global TDS (Transdermal Delivery Systems) Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global TDS (Transdermal Delivery Systems) Sales Forecast by Application (2023-2028) & (K Units)
Table 122. Global TDS (Transdermal Delivery Systems) Sales Market Share Forecast by Application (2023-2028)
Table 123. Global TDS (Transdermal Delivery Systems) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global TDS (Transdermal Delivery Systems) Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global TDS (Transdermal Delivery Systems) Sales Forecast by Region (2023-2028) & (K Units)
Table 126. Global TDS (Transdermal Delivery Systems) Sales Market Share Forecast by Region (2023-2028)
Table 127. Global TDS (Transdermal Delivery Systems) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global TDS (Transdermal Delivery Systems) Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of TDS (Transdermal Delivery Systems)
Figure 2. Global TDS (Transdermal Delivery Systems) Market Share by Type in 2021 & 2028
Figure 3. Single-layer Drug-in-Adhesive Product Picture
Figure 4. Multi-layer Drug-in-Adhesive Product Picture
Figure 5. Others Product Picture
Figure 6. Global TDS (Transdermal Delivery Systems) Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Global TDS (Transdermal Delivery Systems) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global TDS (Transdermal Delivery Systems) Market Size (2017-2028) & (US$ Million)
Figure 12. Global TDS (Transdermal Delivery Systems) Sales (2017-2028) & (K Units)
Figure 13. TDS (Transdermal Delivery Systems) Sales Share by Manufacturers in 2021
Figure 14. Global TDS (Transdermal Delivery Systems) Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest TDS (Transdermal Delivery Systems) Players: Market Share by Revenue in 2021
Figure 16. TDS (Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global TDS (Transdermal Delivery Systems) Sales Market Share by Region (2017-2022)
Figure 18. Global TDS (Transdermal Delivery Systems) Sales Market Share by Region in 2021
Figure 19. Global TDS (Transdermal Delivery Systems) Revenue Market Share by Region (2017-2022)
Figure 20. Global TDS (Transdermal Delivery Systems) Revenue Market Share by Region in 2021
Figure 21. U.S. TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. U.A.E TDS (Transdermal Delivery Systems) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of TDS (Transdermal Delivery Systems) by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of TDS (Transdermal Delivery Systems)
Figure 47. Manufacturing Process Analysis of TDS (Transdermal Delivery Systems)
Figure 48. TDS (Transdermal Delivery Systems) Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Adhex Pharma Harro Hofliger Tesa Labtec Toyochem Teva Pharmaceutical Pfizer IBSA Group Teikoku Seiyaku Endo International Hisamitsu Mylan Sorrento Therapeutics